We demonstrate that relatively short single-stranded oligodeoxynucleotides, 25-61 bases homologous to the target sequence except for a single mismatch to the targeted base, are capable of correcting a single point mutation (G to A) in the mutant ␤-galactosidase gene, in nuclear extracts, episome, and chromosome of mammalian cells, with correction rates of approximately 0.05%, 1% and 0.1%, respectively. Surprisingly, these short single-stranded oligonucleotides (ODN) showed a similar gene correction frequency to chimeric RNA-DNA oligonucleotide, measured using the same system. The in vitro gene correction induced by ODN in nuclear extracts was not dependent on the length or polarity of the oligonucleotide. In contrast, the episomal and
Introduction
The therapeutic nucleic acid repair approach corrects a mutation by targeting oligonucleotide to the genomic DNA or RNA sequence where alteration is required. These approaches use oligonucleotide technology related to triple-helix-forming oligonucleotide [1] [2] [3] [4] and chimeric RNA-DNA oligonucleotide [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] for recognition and repair of the DNA sequence, and antisense oligonucleotides and ribozymes for editing RNA sequence. [17] [18] [19] Unlike gene replacement, where a therapeutic gene is transferred to the cell or affected organ, usually by virus-mediated gene transfer, this approach intends to produce predefined alterations in the DNA or RNA of eukaryotic cells. The advantage of gene repair is that repaired gene can be maintained, expressed, and regulated as the normal endogenous gene. Moreover, oligonucleotide repair could also correct dominant or gain-of-function mutations that are not amenable to gene replacement strategy.
Various approaches have been tried to improve the likelihood of a gene targeting event. One approach utilizes triple-helix-forming oligonucleotide coupled to a reactive chemical group 1, 2 or to a single-stranded or double-stranded deoxyoligonucleotide containing a mismatch to the targeted base. 3, 4 The triple-helix-forming oli- chromosomal gene corrections were highly dependent on the ODN length and polarity. ODN with a homology of 45 nucleotides showed the highest frequency and ODN with antisense orientation showed a 1000-fold higher frequency than sense orientation, indicating a possible influence of transcription on gene correction. Deoxyoligonucleotides showed a higher frequency of gene correction than ribo-oligonucleotides of the identical sequence. These results show that a relatively short ODN can make a sequence-specific change in the target sequence in mammalian cells, at a similar frequency as the chimeric RNA-DNA oligonucleotide. Gene Therapy (2001) 8, 391-399.
gonucleotide recognizes the sequence surrounding a targeted base and the coupled reactive group or DNA elicits DNA repair and/or recombination process, resulting in sequence alteration. Such oligonucleotides have been used previously to change targeted DNA sequences by approximately 1% but are limited by the restrictions of the target sequence, which must consist of homopurine or homopyrimidine stretches for triplex formation.
An oligonucleotide composed of a contiguous stretch of RNA and DNA residues has been developed to facilitate correction of single-base mutations of episomal and chromosomal targets in mammalian cells. 5, 6 Design of the oligonucleotide exploited the highly recombinogenic RNA-DNA hybrids and featured hairpin capped ends avoiding destruction by cellular helicases or exonucleases. The RNA-DNA oligonucleotide was shown to cause a site-specific chromosomal correction or mutation in tissue culture cells and in vivo. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] A permanent and stable gene correction by the RNA-DNA oligonucleotide was demonstrated by clonal analysis at the level of genomic sequence, protein and phenotypic change. 15 The RNA-DNA oligonucleotide might hold promise as a therapeutic method for the treatment of genetic diseases.
Oligodeoxynucleotides (ODNs) have been widely used for inhibition of gene expression as antisense oligonucleotide. The sequence of the antisense oligonucleotide is complementary to the sequence of the mRNA and the antisense oligonucleotide has been shown to hybridize to the target mRNA. Suppression of gene expression was shown to occur by several mechanisms: cleavage and degradation of mRNA or hnRNA by RNase H, inhibition of ribosome binding to mRNA, or inhibition of translation. Single-stranded DNA, however, has also been shown to cause DNA sequence alteration. [20] [21] [22] [23] [24] Gene modification was shown in mammalian cells by a 40-nucleotide single-stranded oligonucleotide. 24 ODNs ranging from 20 to 70 bases have been shown to cause DNA sequence change in yeast cyc1 gene. 20, 21 Frequency of transformation ranged from 10 −5 to 10
, depending on the amount, length, polarity of ODN as well as the genetic background of the recipient yeast. In small-fragment homologous replacement strategy, a 300-400 base singlestranded DNA, was used to generate a homologous replacement in mammalian cells with approximately 1% activity. 22 It has been hypothesized that a strand invasion of single-stranded DNA to the targeted sequence results in pairing of a single-stranded DNA to either strand of the DNA target, similar to homologous recombination.
Here, we demonstrate that relatively short ODNs, 25-61 bases homologous to the target sequence except for a single mismatch to the targeted base, are capable of a sequence-specific correction of a mutant ␤-galactosidase gene. Gene correction has been achieved in the in vitro reaction with nuclear extracts as well as in the episome and chromosome of mammalian cells. Previously, we developed a shuttle system using the mutant ␤-galactosidase plasmid containing a single point mutation (G to A), which results in a loss of enzymatic activity, and measured the frequency of gene correction by chimeric RNA-DNA oligonucleotide. 25 Using the same system, we show that relatively short ODN caused a sequence-specific, length-dependent and strand-specific gene correction in mammalian cells and compared the frequency of gene correction with chimeric RNA-DNA oligonucleotide.
Results

Gene correction by ODN in nuclear extracts
Using an in vitro reaction with nuclear extracts, we compared several designs of oligonucleotide for their gene correction activity. The parameters investigated are the length and polarity of oligonucleotide to the targeted sequence. Synthetic oligonucleotides used in this study are shown in Figure 1 . All oligonucleotides were designed to restore an enzymatic activity of the E. coli ␤-galactosidase by incorporation of a single mismatch to the targeted base, except for ␤-Gal Z1 and ␤-Gal Z2, which contained an identical sequence to the mutant sequence and were used as controls. The importance of length was tested by increasing the homology of oligonucleotide from 25, 35, 45 and 61 bases to the targeted sequence. Strand specificity was investigated by comparing the conversion frequencies between oligonucleotides in the antisense (␤-Gal Q, ␤-Gal W1, ␤-Gal X1 and ␤-Gal Y1) and sense orientation (␤-Gal R, ␤-Gal W2, ␤-Gal X2 and ␤-Gal Y2). At the same time, we tested the activity of the oligonucleotide of an identical sequence but containing 20 residues of RNA interrupted by five DNA residues in the middle, ␤-Gal P and ␤-Gal S. To protect the 3′ and 5′ end of the molecule from nuclease degradation, four residues of 2′-O-methyl uracil residues were incorporated at each end of the ODN.
Initially, we measured the ability of nuclear extracts from DT40 cells to catalyze the in vitro reaction between the mutant LacZ plasmid, pCH110-G1651A, and oligonucleotide. Reaction conditions were optimized by varying the amount of nuclear extracts, the ratio of plasmid DNA and oligonucleotide, and the time of reaction (data not shown). DNA isolated from the in vitro reaction was transformed into E. coli P90C, which has a deletion of the entire lac operon. 26 Thus, transformation of plasmid containing a functional or a mutant ␤-galactosidase gene into P90C bacteria results in either a blue or white colony on an X-gal plate, respectively. The frequency of gene conversion was determined by dividing the number of bacterial colonies carrying corrected lacZ gene (blue) by the total number of bacterial colonies ( Table 1) .
The correction frequency ranged from 2 × 10 −4 to approximately 5 × 10 −4 among ODN with different length and polarity. We found no significant difference in frequency as the length of homology of ODN increased from 25 to 61 nucleotides. Although an antisense ODN showed a slightly higher frequency than a sense ODN, it may not be significant considering the standard deviation. Thus, neither the length nor the polarity of ODN affected appreciably the frequency of gene correction in the in vitro reaction. An oligonucleotide containing 20 RNA residues and five DNA residues of the identical sequence, ␤-Gal P and ␤-Gal S, showed a frequency of less than 10
. Thus, deoxyoligonucleotides exhibited higher gene correction frequency than RNA oligonucleotides of the same sequence.
The ␤-Gal Z1 and ␤-Gal Z2, ODNs with no mismatch, did not generate any blue colonies among 10 6 white colonies generated in five independent experiments, indicating a sequence-specific correction. Previously, we examined the possibility that the sequence conversion might be mediated by E. coli and established that the gene correction event occurred in mammalian cells and not in bacteria. 25 The plasmid and a single-stranded ODN were incubated with nuclear extracts separately, combined after phenol extraction and ethanol precipitation, and electroporated to P90C bacteria. We have not found any blue colonies in this experiment (data not shown). This result argues against the possibility that a single-stranded ODN can be extended in bacteria to cause potential artifacts.
To verify the nature of the Lac + phenotype revertants, we performed RFLP analysis of DNA from 20 blue colonies followed by sequencing of the region surrounding the point mutation at position 1651. All examined blue colonies exhibited a correction of AAA codon to GAA at position 1651 and no other DNA sequence change was observed in flanking regions (data not shown).
Episomal correction of a point mutation by ODN by transient transfection
To investigate the feasibility of ODN-based gene correction in mammalian cells, we performed episomal targeting by transient transfection of pCH110-G1651A plasmid and ODN in CHO-K1 cells. Cells were stained with X-gal solution for the presence of active ␤-galactosidase expression 48 h after transfection. When cells were transfected with the mutant plasmid DNA alone or cotransfected with plasmid and ␤-Gal Z1 or ␤-Gal Z2, a complete absence of ␤-galactosidase enzymatic activity was observed (data not shown). Similar to the in vitro reaction, we did not see any staining when cells were cotrans- 
a Frequency of gene correction was averaged among the results obtained from two separate in vitro reactions performed by least three different preparations of DT40 nuclear extracts. For each set of experiments, the same nuclear extracts were used for all oligonucleotides for consistency. One tenth of the DNA from in vitro reaction was transformed into electro-competent P90C bacteria and plated into 10 LB dishes containing 100 g/ml X-gal and 50 g/ml ampicillin. The number of blue colonies was divided by the total number of colonies.
Gene Therapy fected with an RNA oligonucleotide, either ␤-Gal P or ␤-Gal S (data not shown). However, in contrast to the in vitro reaction, the number of blue cells increased in CHO-K1 cells as the length of ODN increased ( Figure 2a ). ODNs with a homology length of 35 and 45 nucleotides showed two-and four-fold higher gene correction frequency, respectively, in comparison to ODN with a homology length of 25 ( Figure 2b ). When the homology was extended to 61, a slight decrease was observed. The frequency of gene correction in the episome (0.5 to approximately 1%) was higher than that of the in vitro reaction (0.05%). Furthermore, in contrast to the in vitro reaction, two ODNs with the same length but opposite polarity showed a strikingly different gene correction frequency (Figure 2a and b ). An antisense oligonucleotide showed a 1000-fold higher frequency than a sense oligonucleotide. Sequence analysis of bacterial colonies generated by Hirt DNA isolated from transient transfection confirmed the correction of AAA to GAA at position 1651 (data not shown). Thus, ODN caused a sequence-specific, homology length-dependent, and strand-specific gene correction in the episome of mammalian cells.
Chromosomal correction of a point mutation by ODN To investigate the feasibility of ODN gene correction at the chromosomal level, we generated several stable cell lines where the mutant LacZ gene was integrated and expressed. Ten independent clones were generated and subjected to Western blot analysis using a monoclonal antibody, which recognized both wild-type and mutant ␤-galactosidase. For systematic study, we selected clone 14, which expressed the highest level of mutant protein (data not shown). Increasing numbers of blue cells were detected as the dose and length of ODN increased (Figure 3a) . Similar to the episomal targeting, ODN with a homology length of 35 and 45 base increased the frequency of correction to two-and four-fold, respectively, in comparison to ODN with a homology length of 25 bases (Figure 3b) . Interestingly, the frequency decreased when the homology was extended to 61, indicating an optimum length of ODN exists for gene correction. The frequency of gene correction in the chromosome (approximately 0.1%) was lower than that in the episome (approximately 1%). We also found a drastic difference in gene correction frequency between two oligonucleotides with the same length but opposite polarity, similar to the episomal targeting. Thus, ODN caused a sequence-specific, homology length-dependent, and strand-specific gene correction in the chromosome of mammalian cells.
ODN uptake and stability
It is generally necessary to use chemically modified oligonucleotides in cell-based systems in order to prolong oligonucleotide half-life, thereby allowing sufficient time for ODNs to reach sites of action and perform intended functions. To protect the 3′ and 5′ ends of the molecule, four residues of 2′-O-methyl uracil were incorporated at each end of the ODN. Unmodified oligonucleotides showed rapid degradation (data not shown). Cellular stability of the ODN was measured by transfection of a trace amount of 32 P 5′-end-labeled ODN into CHO-K1 cells. At various time intervals, 6 and 24 h after transfection, ODN was isolated as described in Materials and methods and analyzed by polyacrylamide gel electrophoresis followed by autoradiography (Figure 4) . The amount of radioactivity in total lysates after 6 h and 24 h was 1% and 0.1% of the initial amount of the 32 P endlabeled ODN, ␤-Gal W1, ␤-Gal X1 and ␤-Gal Y1, respectively. This result indicates a substantial degradation of the ODN during 24 h. To investigate whether different degraded products are generated after prolonged incubation, the same 32 P counts were loaded in each lane for comparison (Figure 4) . Only full-length ODN was detected by autoradiography, indicating that remaining ODN was intact and stayed as a monomer inside the cells. Assimilation of both sense and antisense ODN occurred into the homologous plasmid DNA encoding the mutant ␤-galactosidase but not into the heterologous plasmid encoding the alkaline phosphatase (compare lanes 5, 6 and 7, 8 in Figure 5 ). Higher concentration of heterologous DNA at 20 nm did not promote any D-loop formation (data not shown). The sense and antisense ODN showed the same extent of D-loop formation, in agreement with similar activity found in the in vitro reaction. Both the nicked circle and linear forms of dsDNA showed incorporation of ODN but not the superhelical DNA. Within 5 min of incubation with nuclear extracts, the superhelical DNA was completed converted into the nicked circle and linear forms, detected by ethidium bromide staining (data not shown). Thus, it is possible that the initial incorporation of ODN into superhelical DNA could have been converted to the D-loop formation between ODN and the nicked circle and linear forms. It has been shown that the D-loop formation can result from nonenzymatic base pairing of a homologous single strand and superhelical DNA. 27 When the D-loop formation was performed between ODN and homologous DNA in the absence of nuclear proteins, no forms of Gene Therapy 32 
Figure 5 D-loop formation promoted by nuclear proteins. Reaction containing
P-labeled ␤-Gal X1 (AS) or ␤-Gal X2 (S) was incubated with homologous (h) or heterologous (ht) superhelical DNA as described in Materials and methods. D-loop formation was performed in the absence (lanes 1-4) or presence (lanes 5-10) of nuclear extracts. Except for lanes 9 and 10 where the concentration of dsDNA was increased to 20 nm, all reactions were carried out with 2 nm of dsDNA and 84 nm ODN. The arrows indicate different forms of dsDNA: nicked circle (NC), linear (L) and superhelical (SC) DNA. The position of D-loop was found in the NC and L forms of plasmid.
dsDNA showed incorporation of radioactivity (lanes 3, 4 in Figure 5 ). This result indicates that D-loop formation was catalyzed by nuclear proteins and was dependent on sequence homology and the amount of superhelical DNA.
Discussion
Previously, we showed a targeted gene correction of the mutant E. coli ␤-galactosidase gene containing a single point mutation by the chimeric RNA-DNA oligonucleotide and reported a frequency of approximately 0.1% by in vitro reaction using nuclear extracts and approximately 1% by transient transfection. 25 Using the same system, we investigated whether a single-stranded oligonucleotide can alter the DNA sequence and compared its efficacy with the chimeric RNA-DNA oligonucleotide, in the in vitro reaction with nuclear extracts as well as in the episome and chromosome of mammalian cells. Surprisingly, we found that relatively short oligodeoxynucleotides caused gene correction in mammalian cells to a similar extent as the chimeric RNA-DNA oligonucleotide. Gene correction frequency of the in vitro reaction was approximately 0.05% and was not dependent on the length or polarity of the oligonucleotide. In contrast to the in vitro reaction, frequency of episome gene correction was highly dependent on the length and polarity of the oligonucleotide and ranged from 0.5% to 1% in CHO-K1 cells. Gene correction required an optimum length with a homology of 45 nucleotides showing the highest frequency. Moreover, an antisense oligonucleotide exhibited a 1000-fold higher frequency of gene correction than a sense oligonucleotide. Chromosomal gene correction showed a similar dependence on the length and polarity of oligonucleotide to the episome, albeit occurring at a lower frequency, approximately 0.1% in CHO-K1 cells. Thus, ODNs caused a sequence-specific, length-dependent and strand-specific gene correction in episome and chromosome of mammalian cells.
Gene correction frequencies of episomal DNA were much higher than those observed in nuclear extracts. This result indicated that some proteins might be excluded or inactivated during preparation of nuclear extracts. Episomal gene correction frequency was higher than chromosomal. Differences could be caused by the chromatin structure, which may limit the accessibility of target chromosomal DNA. It may be that chromosomal recombination may be different from episomal, which has been shown to occur by a nonconservative single-strand annealing mechanism. [28] [29] [30] Correction of a single plasmid among multiple copies of uncorrected plasmids present in transfected cells may result in the restoration of ␤-galactosidase activity (blue cells), resulting in an apparent high frequency of episomal targeting.
The initial step for gene correction would involve a pairing of ODN with the homologous DNA sequence by recombination, which would provide a good starting point for the mechanism study. To correlate gene repair activity with such a formation, we performed the D-loop formation at similar conditions where we measured gene repair activity. We found that nuclear proteins catalyzed similar extents of the D-loop formation between either sense or antisense ODN and the homologous superhelical DNA. This result suggests a pairing of ODN with either strand of the homologous superhelical DNA and is in agreement with the similar in vitro gene correction frequency exhibited by both ODNs. In all cases, however, deoxyoligonucleotides showed higher frequency of gene correction than RNA oligonucleotides of identical sequence. The mismatch repair activity was less efficient in the RNA-DNA duplex than in the DNA-DNA duplex. 31, 32 We 33 and others 34, 35 also found that a singlebase correction in the target DNA is preferentially driven by the DNA-containing strand but not by the RNA-containing strand of the chimeric RNA-DNA oligonucleotide. Therefore, the higher frequency of gene correction exhibited by the deoxyoligonucleotide in comparison to the ribo-oligonucleotide could be attributed to the DNA repair activity. Comparison of repair mechanisms by chimeric RNA-DNA oligonucleotide and single-stranded ODN will be presented elsewhere.
In contrast to the in vitro reaction with nuclear extracts, the episomal or chromosomal gene correction was highly dependent on the length and polarity of ODN. D-loop formation by nuclear extracts also showed no appreciable differences between antisense and sense ODN of different lengths, indicating a good correlation between recombination and in vitro gene correction activity. Because ODNs appear to be quite stable and remained as a fulllength monomer in mammalian cells, the increased gene correction frequency found in longer ODN is not likely to be caused by the stability of ODN. Therefore, the optimal length of ODN found in episome and chromosome suggests that other factors, such as the size and structure of a transiently open chromatin, may play a role in initiating recombination.
For the episome and chromosome targets, two ODNs with the same length but opposite polarity showed a drastic difference in gene correction frequency, which reveals for the first time the potential effect of transcription on gene repair by short ODN. Transcription has been linked to preferential repair of the transcribed strand and to stimulating recombination. [36] [37] [38] [39] The preferential action of the antisense ODN could be due to strand separation during transcription, which causes opening of the chromatin allowing increased accessibility to the nontranscribed strand, while the transcribed strand may be occupied by the RNA polymerase and accessory proteins. The other possibility is that both oligonucleotides have an equal capacity for heteroduplex formation but only one orientation will result in DNA sequence correction, due to the strand specificity of the mismatch repair system. 40 In this case, the sense oligonucleotide could make a heteroduplex with the transcribed strand but is excised and eliminated by the DNA repair system, which favors the resident strand over the invading strand, resulting in no gene correction. 41 We plan to pursue the mechanism of the transcription-linked gene repair process in the future. Because antisense oligonucleotides could potentially hybridize to the mRNA and inhibit protein production, it is possible that the frequency of antisense oligonucleotides could be higher than that measured in this study. In transformation of yeast by ODN, the sense strand affected the target 50-to 100-fold more than the antisense oligonucleotide, 21 independent of the transcription rate of the gene. At this time, it is not clear why such a difference exists between yeast and mammalian cells.
Chan et al 3 showed that a bifunctional ODN, containing a triple helix domain and a donor fragment ranging from 40 to 44 nucleotides homologous to the target DNA, except for one mismatch, corrected a point mutation. In their study, the sense and antisense ODN showed a similar frequency, which was lower than the bifunctional ODN. Here, we found that gene correction frequency of the single-stranded ODN was highly dependent on polarity. Differences between these two studies may stem from the different shuttle systems and assays. For example, the supF gene used in the bifunctional oligonucleotide was not transcribed, while the ␤-galactosidase gene used in this study was transcribed in mammalian cells. We also found that neither the length nor polarity of ODN affected appreciably the frequency of gene correction in the in vitro reaction, where the ␤-galactosidase gene was not transcribed. Furthermore, Chan et al measured frequency by transformation of the replicated episomal DNA in mammalian cells into bacteria, while we measured frequency by direct detection of the corrected ␤-galactosidase gene expressed in mammalian cells. It is possible that these factors may contribute to the differences found between the two studies.
This study reports two surprising findings. First, short single-stranded oligonucleotides are capable of gene correction similar in extent to the corrections obtained with chimeric RNA-DNA oligonucleotide in the same system. Second, there is a striking difference in gene repair activity measured by the in vitro reaction with nuclear extracts and in vivo assays, which include transient transfection and chromosomal targeting. While this paper was being reviewed, Gamper et al 42 reported that singlestranded ODN corrected point and frameshift mutations by incubation of HuH7 cell extracts with the plasmid encoding antibiotic resistance in E. coli. Their results are in agreement with our findings that short single-stranded oligonucleotides are capable of in vitro gene correction, obtained by using different shuttle vector and bacterial readout systems. However, we have further compared gene correction between in vitro reaction and in vivo assays, because our shuttle vector is expressed in both mammalian and bacterial cells. In contrast to the in vitro Gene Therapy reaction with nuclear extracts, episomal or chromosomal gene correction was highly dependent on the length and polarity of ODN. Therefore, gene repair strategy by single-stranded ODN in mammalian cells requires the comprehensive in vivo assays presented in this study in addition to the in vitro reaction. With this finding, a relatively short deoxyoligonucleotide can be envisioned to make a sequence-specific change in the target sequence in mammalian cells, at a similar frequency as the chimeric RNA-DNA oligonucleotide.
Materials and methods
Synthesis and purification of oligonucleotides The oligonucleotides were synthesized on an Applied Biosystems (Foster City, CA, USA) model ABI 392 RNA/DNA synthesizer, using a 1 mol scale by standard phosphoramidite procedure. Chemicals used for synthesis were purchased from Glen Research (Sterling, VA, USA) and Perkin Elmer (Foster City, CA, USA). The oligonucleotides were purified by the procedure described previously. 5 
Plasmids
The mammalian shuttle vectors pCH110-G1651A and pcDNA3.1/Zeo/G1651A contain the lacZ gene with an inactivating G-to-A point mutation at position 1651. The plasmid pCH110-G1651A has been described previously. 25 The pcDNA3.1/Zeo/G1651A plasmid was constructed by inserting a 3.7-kb fragment that contained the mutant lacZ gene into the BamHI-HindIII sites of pcDNA3.1/Zeo(+) plasmid (Invitrogen, Carlsbad, CA, USA).
Cell cultures, transfection and selection All media and fetal bovine serum (FBS) were from Gibco BRL and were supplemented with 2 mm l-glutamine. CHO-K1 cells (ATCC, Rockville, MD, USA) were maintained in F12 medium containing 10% heat-inactivated FBS. DT40 cells were grown in RPMI 1640 medium containing 10% heat-inactivated FBS, 1% chicken serum (Sigma, St Louis, MO, USA) and 50 m 2-mercaptoethanol (Sigma). All cells were grown at 37°C and 5% CO 2 .
Several stable cell lines containing the integrated mutant LacZ gene were generated by transfection of the pcDNA3.1/Zeo/G1651A construct into CHO-K1 cells. The transfected cells were split 1:10 into multiple 10-cm plates and selected by 1 g/ml Zeomycin for 16 days. Individual Zeomycin-resistant colonies were selected using a cloning cylinder and grown into 24-well culture plate. Ten clones were characterized at the DNA sequence level by RFLP analysis of genomic DNA. Expression of the mutant ␤-galactosidase was determined by Western blot using a monoclonal anti-␤-galactosidase antibody (Oncogene, Boston, MA, USA), which recognized both wild-type and mutant protein.
Nuclear extract preparation and in vitro analysis of gene conversion Nuclear extracts were prepared from DT40 cells as previously described. 25 The standard in vitro reaction mixture contained 200 pm of supercoiled pCH110-G1651A DNA and 2 m of ODN in a reaction buffer containing 30 mm Hepes (pH 7.8), 7 mm MgCl 2 , 4 mm adenosine triphosphate (ATP), 200 m each of cytosine triphosphate (CTP), guanosine triphosphate (GTP), uridine triphosphate (UTP), 100 m each of deoxy-ATP, deoxy-GTP, deoxy-CTP, deoxythymidine triphosphate (dTTP), 40 mm creatine phosphate, 100 g/ml creatine phosphokinase and 15 mm sodium phosphate (pH 7.5). Incubation was carried out at 37°C for 1 h. After reaction, the DNA was purified by phenol-chloroform extraction and precipitated with ethanol. Twenty percent of the recovered DNA was electroporated into E. coli strain P90C (setting 25 F, 250 W and 0.1 cm cuvette) and transformants were plated on to an LB-dish containing 50 g/ml of ampicillin and 100 g/ml of X-gal. The P90C [ara⌬(lac proB) XIII ] has a deletion of the entire lac operon. 26 The frequency of correction was measured by dividing the number of blue colonies by the total number of colonies.
RFLP analysis and DNA sequencing Blue and white colonies generated by in vitro reaction were isolated and subjected to PCR amplification by using two primers, 5′-GATGAAGCCAATATTGAAACC-3′ and 5′-CTGGTCTTCATCCACGCG-3′. The gene conversion was measured by HinfI digestion of the 300 bp PCR product. The HinfI digestion of the PCR product from the white colony (AAATC) generates two fragments of 262 and 38 bp. In contrast, the PCR product from the blue colony (GAATC) generates 150, 112 and 38 bp fragments after HinfI digestion. The plasmid DNA was subjected to a direct DNA sequencing by automatic DNA sequencer (ABI 373A; Applied Biosystems) using the primer, 5′-GATGAAGCCAATATTGAAACC-3′.
Transfection and histochemical staining
For episomal targeting experiments, 5 × 10 4 cells were seeded per well in a six-well plate 16-18 h before transfection. Oligonucleotide (1 m) and pCH110-G1651A plasmid (2 nm) were incubated with 15 g Lipofectamine (Gibco, Bethesda, MD, USA) in 1 ml Optimem for 45 min and added to the cells. Cells were fed with 2 ml of complete medium 6 h later and stained 48 h after transfection. For histochemical staining, cells were washed three times with ice-cold PBS and fixed for 5 min in 1% glutaraldehyde at 4°C. After removal of fixation solution, cells were washed three times with PBS and then stained with X-gal solution (5 mm K 3 Fe 3 (CN) 6 , 5 mm K 4 Fe 2 (CN) 6 , 1 mm MgCl 2 and 1 mm X-gal (5-bromo-4-chloro-3-indolyl-␤-d-galactoside)) in 1× PBS (pH 8.0) at 37°C overnight. In order to prevent expression of endogenous mammalian ␤-galactosidase, histochemical staining was carried out at pH 8.0. Under these conditions only bacterial ␤-galactosidase was shown to be active. Blue cells were counted per each well by light microscopy.
For genomic targeting, 5 × 10 4 cells were seeded per well in a six-well plate 16-18 h before transfection. For lipofection, various amounts of ODN ranging from 5 to approximately 15 g, was diluted to 100 l with Optimem and added to 15-25 g Lipofectamine in a final volume of 200 l, made up with optimem. Complexes were allowed to form for 45 min and added to cells in a final volume of 1 ml, made up with optimem. Cells were fed with 2 ml of complete medium 6 h later and stained 48 h after transfection.
Oligonucleotide uptake measurement and stability Cellular uptake of oligonucleotide was measured in crude cellular lysate. The 32 P end-labeled oligonucleotide was transfected as described above. At various times after transfection, cells were extensively washed with PBS, followed by an acid wash in 1.5 m NaCl, pH 2.5, to strip off oligonucleotide bound to the plasma membrane. Cells were lysed in 1 ml of Nonidet 40 solution (140 mm NaCl, 10 mm Tris-HCl, pH 7.5, 1.5 mm MgCl 2 , 0.5% Nonidet 40). After quantifying 32 P in each lysate, the samples were analyzed by 12% polyacrylamide gel electrophoresis containing 7 m urea followed by autoradiography. For gel electrophoresis, a crude lysate was further purified by phenol-chloroform extraction followed by desalting using a G-25-spin column (Boehringer, Indianapolis, IN, USA).
D-loop formation between ODN and superhelical dsDNA Twenty micrograms of nuclear proteins from DT40 cells were preincubated at room temperature for 5-10 min with 84 nm 32 P-labeled ␤-Gal X1 or ␤-Gal X2 in a reaction mixture (20 l) containing 20 mm Tris-HCl, pH 7.4, 1 mm DTT, 5 mm MgCl 2 , 2 mm ATP, and 100 g/ml bovine serum albumin. After preincubation, superhelical pCH110-G1651A DNA was added at 2 nm or 20 nm into the reaction mixture and incubated at 37°C for 5 min. The heterologous DNA, p711 plasmid encoding the alkaline phosphatase gene, 5 was used as control. Reaction was stopped by addition of 0.5% SDS and 2 mg/ml proteinase K at 37°C for 15-20 min. The deproteinized products were analyzed on a 0.8% agarose gel in TBE buffer (45 mm Tris/45 mm boric acid/pH 8.0/0.001 EDTA) containing 5 mm MgCl 2 and run at 2.5-3.0 V/cm for 17-19 h at 4°C. In all reactions, the same amount of radioactivity was added. The gel was dried and visualized by ethidium-bromide staining. 32 P-labeled DNA was detected by autoradiography at −80°C for 24-48 h.
